Medistep promoters confirm no share encumbrance for FY26
Medistep Healthcare Limited disclosed to the National Stock Exchange that its promoters did not create any encumbrance on their shares during the financial year ended March 31, 2026. The declaration, signed by Promoter Girdharilal Prajapat on April 2, 2026, was submitted in compliance with Regulation 31(4) of the SEBI (SAST) Regulations, 2011.
*this image is generated using AI for illustrative purposes only.
Medistep Healthcare Limited has communicated to the National Stock Exchange of India Ltd. that its promoters have not encumbered any shares held by them during the financial year ended March 31, 2026. This disclosure was submitted to the exchange on April 2, 2026, in accordance with regulatory requirements.
Declaration Details
The declaration was filed under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeover) Regulations, 2011. This regulation requires promoters to confirm whether they have created any encumbrance, directly or indirectly, on their shareholding during the relevant financial year.
| Particulars | Details |
|---|---|
| Regulation | Regulation 31(4) of SEBI (SAST) Regulations, 2011 |
| Financial Year | Year ended March 31, 2026 |
| Encumbrance Status | No encumbrance made directly or indirectly |
| Declaration Date | April 2, 2026 |
Promoter Confirmation
The confirmation was provided on behalf of all promoters of the company. Girdharilal Prajapat, a Promoter of Medistep Healthcare Limited , signed the declaration. The document explicitly states that no shares held by the promoters were subject to any encumbrance during the specified period. The company has requested the exchange to place this information on record.
Historical Stock Returns for Medistep Healthcare
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +16.67% | -3.67% | +10.53% | -22.22% | -58.29% | -58.29% |
How does Medistep Healthcare's clean promoter shareholding record influence institutional investor confidence and potential future fundraising activities?
Could the absence of promoter share encumbrances signal upcoming strategic expansions or acquisitions by Medistep Healthcare in the coming fiscal year?
How does Medistep Healthcare's promoter shareholding stability compare to peers in the Indian healthcare sector, and what does this mean for its competitive positioning?
16
Access 50+ Readymade Screeners 
Use 200+ Custom Filters 
Get Full Market Insights 
